AZLI 75 mg two times a day (BID)/ three times a day (TID)
CP-AI-006
Phase 3 small_molecule completed
Quick answer
AZLI 75 mg two times a day (BID)/ three times a day (TID) for Cystic Fibrosis is a Phase 3 program (small_molecule) at Gilead Sciences Ireland UC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Gilead Sciences Ireland UC
- Indication
- Cystic Fibrosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed